Tempur Sealy's Relative Performance & Potential Mattress Firm Acquisition Prompt 28% Price Target Boost By This Analyst

• Raymond James analyst Bobby Griffin reiterated a Strong Buy rating on the shares of Tempur Sealy International Inc (NYSE: TPX) and raised the price target from $35 to $45.

• While industry trends remain negative, the analyst is starting to see evidence demand is stabilizing and Tempur-Sealy continues to perform well on a relative basis versus its peers.

• 2022 U.S. bedding units likely ended down 15% - 20% y/y, flushing out the 2-year COVID bump in the analyst's opinion and bringing consumption back below 2017 levels.

• Accordingly, even with the current macro environment, 2022 could mark the low point in earnings for TPX, especially if inflation continues to modestly moderate in 2023, added the analyst.

• TPX's stock has made a strong move over the last three months (up 36%), as the potential for Serta Simmons' bankruptcy increased and speculation is growing for a potential Mattress Firm acquisition following Mattress Firm pulling its S-1 filing, said the analyst.

• Nonetheless, in the analyst's view, the fundamentals on TPX remain intact. The analyst continues to view the risk/reward set-up favorably with EPS likely bottoming in 2022/early 2023, and solid earnings growth potential over the medium to long-term.

• Given the change in Mattress Firm's IPO plans, the current industry dynamics (SSB filing bankruptcy), and the view that 2022/early 2023 could mark the bottom for units, the analyst's curiosity about a potential deal has also increased.

• According to the analyst, the Mattress Firm acquisition would be highly accretive to Tempur Sealy.

• On a high level, Tempur Sealy acquiring Mattress Firm could make sense given the vertical integration of the two businesses and recapture of gross profit dollars on the consolidated business, the analyst specified.

• Price Action: TPX shares are trading higher by 1.45% at $38.88 on the last check Thursday.

• Photo Via Company

Latest Ratings for TPX

Date	Firm	Action	From	To
Feb 2022	Wedbush	Maintains		Outperform
Feb 2022	Raymond James	Maintains		Strong Buy
Feb 2022	Keybanc	Maintains		Overweight

View More Analyst Ratings for TPX

View the Latest Analyst Ratings

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article originally appeared on Benzinga.com

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.